Virginia theranostics program takes shape with Sentara-BAMF
The joint venture is intended to combine radiopharmaceutical production, molecular imaging, molecular therapy, and clinical trials in a vertically integrated model.
Sentara Health and BAMF Health are forming a joint venture to create what they describe as Virginia’s first comprehensive vertically integrated theranostics program.
The program is designed to combine radiopharmaceutical production, molecular imaging, molecular therapy, and clinical trials. Sentara said it already offers molecular imaging through PET/CT scanning, while BAMF Health specializes in designing, building, and operating vertically integrated theranostics centers.
Cancer will be the initial clinical focus. The companies also said clinical trials are investigating theranostics applications for neurological disorders such as Parkinson’s disease, cardiovascular conditions, and other diseases.
Theranostics uses molecular imaging to identify disease targets, followed by radiopharmaceutical therapy directed at those targets. Sentara described the approach as precision medicine using molecular features of a patient’s disease to guide diagnosis and treatment.
Radiation-safety infrastructure is part of the planned program. Sentara said it is supporting regulatory and compliance requirements because theranostics involves radioactive medications.
BAMF Health said the program will serve patients across Virginia and the surrounding region. The company also said the venture will expand access to radiopharmaceutical therapies and related clinical trials.
The partnership follows BAMF Health’s other theranostics expansion work. In April, BAMF Health and Henry Ford Health broke ground on a 45,000-square-foot comprehensive theranostics center in downtown Detroit, according to BAMF’s news page.
Sentara is an integrated, not-for-profit health system with 12 hospitals in Virginia and northeastern North Carolina, more than 400 sites of care, and more than 2,000 physicians and advanced practice providers, according to BAMF’s release.
Companies:Sentara Health, Bamf Health
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
uMI Panvivo Mobile joins United Imaging PET lineup
United Imaging used SNMMI 2026 to show new PET/CT and PET/MR systems, including uMI Panvivo Mobile, uMI Panorama GS, and uPMR Zenith.
Idaho Falls site added to RTX-2358 manufacturing plan
PharmaLogic will expand production capacity for Ratio Therapeutics’ Ac-225 RTX-2358 as the FAP-targeted radiopharmaceutical moves through ATLAS clinical testing.
Ilumira authorization opens EU route for SHINE Lu-177
The EMA-authorized radiopharmaceutical precursor is produced at SHINE’s Cassiopeia facility in Wisconsin for use in radiolabelling carrier medicines.
Lead-212 supply pact links Eckert & Ziegler, Thor Medical
hor Medical will initially supply Pb-212 to Eckert & Ziegler for preclinical R&D, while the companies explore broader isotope-production and radiopharmaceutical-manufacturing integration.
Aidoc creates growth post for enterprise AI push
Christopher Young will lead global expansion, partnerships, and enterprise growth after prior healthcare technology roles at BCG and Ascension.
Everlight shifts global teleradiology stack to RadOS
The 5-year agreement will put Sirona Medical’s cloud-native platform across Everlight’s operations in 6 markets, covering PACS, reporting, worklist, archive, and AI workflows.
HCA’s CHCP deal includes imaging CE provider MTMI
HCA Healthcare agreed to acquire CHCP, a Texas allied-health education provider that owns MTMI and offers programs in sonography, radiologic technology, and medical coding.
CBCT perfusion collaboration targets stroke angio suite
Siemens Healthineers and Cercare Medical are pairing Syngo DynaCT Multiphase with Neurosuite to support perfusion imaging during acute stroke interventions.
RC Capital backs Captive’s PET-CT expansion
Captive Radiology said the investment will help scale turnkey imaging programs as demand grows for PET-CT, MRI, and theranostics-related services.
Pathology support broadens MedDream viewer scope
Version 8.9.0 is scheduled for June 2026 through aycan and will add support for pathology workflows and saving reconstructed MPR viewports as new study series.
DOSIsoft unit gives PLANET a theranostics focus
DOSIsoft Theranostics will operate within the DOSIsoft group, with its own partnerships and investment strategy centered on PLANET software.
Vault-ready proton system headed to Tam Anh
Mevion said the S250-FIT installation would be Vietnam’s first proton therapy system, with operation expected as early as late 2027 at Tam Anh’s Phu My Hung facility.